Diagnostic Accuracy of the RapidFor™ RSV/ADV Rapid Test Kit Compared with PCR for the Detection of Respiratory Syncytial Virus and Adenovirus in Nasopharyngeal Swab Samples

When a child arrives at an emergency room with a fever, a cough, and trouble breathing, the medical team faces a familiar but difficult puzzle. The symptoms of many different viruses look almost identical on the surface, yet the causes require very different approaches to treatment. Two of the most common culprits behind these respiratory illnesses in children are the respiratory syncytial virus, often called RSV, and adenovirus. While RSV is notorious for hitting infants hardest, causing severe lower respiratory infections, adenovirus can strike at any age and often brings along eye irritation and sore throats alongside breathing problems. For decades, the gold standard for identifying these germs has been a laboratory test called polymerase chain reaction, or PCR. This method is incredibly precise, acting like a high-powered microscope that can find the genetic fingerprint of a virus even when only a tiny amount is present. However, this precision comes with a cost: the test takes hours or even days to return results because it requires specialized equipment and a central laboratory. In the fast-paced environment of a busy emergency department, waiting that long can delay decisions about whether to admit a child to the hospital, how to isolate them from other patients, or whether to prescribe antibiotics that might not be needed at all.

Researchers in Istanbul set out to see if a faster, simpler tool could solve this problem without sacrificing accuracy. They evaluated a new rapid test kit called RapidFor™, which is designed to detect both RSV and adenovirus from a single sample in just a few minutes. Unlike the complex PCR method, this kit works like a home pregnancy test, using a strip that changes color to show a result right at the bedside. The team wanted to know if this quick method could stand up to the rigorous standards of the laboratory gold standard across the entire spectrum of childhood, from newborns to teenagers. They gathered 302 children who had come to the emergency department with acute respiratory symptoms between February and May 2025. For every child, the medical team collected two swabs from the back of the nose. One swab was used immediately for the rapid test, while the other was sent to the lab for the definitive PCR analysis. This setup allowed the researchers to compare the instant results directly against the final, confirmed truth.

The results of the study were strikingly clear. The rapid test proved to be remarkably accurate, matching the laboratory results in nearly every case. For adenovirus, the test correctly identified the virus in 98.31% of the children who actually had it, and it correctly ruled out the virus in 98.77% of those who did not. The performance for RSV was almost identical, with a success rate of 98.28% for finding the virus and 98.77% for correctly identifying when it was absent. In statistical terms, the agreement between the quick test and the slow, complex lab test was excellent, meaning the rapid kit rarely gave a false alarm or missed a real infection. This high level of accuracy held true across almost all age groups, though the researchers noted that the test performed slightly differently depending on the child's age and the specific virus. For instance, the test was perfect at identifying adenovirus in children between the ages of one and three, and again in those between four and six, but it showed a tiny number of errors in the youngest infants and older school-aged children.

Beyond simply checking the test's accuracy, the study also shed light on how these two viruses behave differently in children. The researchers found that the age of the child was a strong clue to which virus was likely present. RSV was overwhelmingly found in infants under one year old, where it accounted for more than half of the positive cases in that group. In contrast, adenovirus was much more common in school-aged children, particularly those between seven and twelve years old. The symptoms also told a different story for each virus. Children with adenovirus were far more likely to have a high fever and red, irritated eyes, while those with RSV almost always had a persistent cough. The study confirmed that these clinical signs could help doctors guess the cause, but they also showed that symptoms alone were not enough to be certain. A child with a fever and red eyes might have adenovirus, but without a test, a doctor could not be sure.

The implications of these findings are significant for how pediatric emergency rooms operate. Because the rapid test can deliver a reliable answer in minutes, it allows doctors to make immediate decisions about patient care. If the test shows a child has RSV or adenovirus, the medical team knows the illness is viral and that antibiotics, which only work against bacteria, will not help. This knowledge can prevent the unnecessary use of drugs that contribute to antibiotic resistance. Furthermore, knowing the specific virus helps the hospital decide how to group patients to prevent the spread of infection. A child with RSV might need to be kept away from other infants, while a child with adenovirus might require different isolation precautions. The study suggests that this combined rapid test could be a powerful tool for streamlining care, reducing the time children spend in the waiting room, and ensuring that the right treatment is given right away. While the researchers caution that more studies are needed to confirm these results across different seasons and locations, the evidence from this large group of children indicates that a quick, simple test can now provide answers that were once reserved for the laboratory.